Drug:
Reaction: HYPERSENSITIVITY
20260101 - 20261231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 26863036 |
PA |
2 | |
Metastases to lung, Metastases to liver, Metastases to spine, Choking sensation, Feeling hot, Food allergy, Pruritus, Rash erythematous, Nasopharyngitis, Cough, Erythema, Sensitive skin, Skin exfoliation, Skin abrasion, Pain in extremity, Hypokinesia, Pleural mass, Hypersensitivity, Laziness, Feeling abnormal, Alopecia, Dry skin, Skin atrophy, Dizziness, Arthralgia, Somnolence, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, CALCIUM, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, FOLIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 602 | 26863243 |
US |
2 | |
Rash, Skin exfoliation, Hypersensitivity, |
||||
OMALIZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 603 | 26863503 |
CA |
2 | |
Immunodeficiency, Joint swelling, Hyperhidrosis, Headache, Pain, Dysphagia, Hypertension, Hypersensitivity, Hepatic enzyme increased, Food allergy, Infusion related reaction, Exposure during pregnancy, Overdose, Prescribed overdose, Off label use, Intentional product misuse, Product use issue, |
||||
GABAPENTIN, ABACAVIR SULFATE, ABACAVIR, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUPROPION, BUPROPION, BUPROPION, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CLONIDINE, CLONIDINE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, ETANERCEPT, FLUCONAZOLE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FUROSEMIDE, ADALIMUMAB, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MONTELUKAST, MONTELUKAST, MONTELUKAST, MORPHINE, MORPHINE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, ABATACEPT, ABATACEPT, ABATACEPT, PROGESTERONE, PROGESTERONE, PROGESTERONE, PSYLLIUM HUSK, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE, RANITIDINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, TEMAZEPAM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNOSIDES, SENNOSIDES, SENNOSIDES, SENNOSIDES, SENNOSIDES, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, VITAMIN C, BUPROPION HYDROCHLORIDE, |
||||
| 604 | 26863585 |
US |
||
Pain, Paraesthesia, Burning sensation, Dysstasia, Rash, Hypersensitivity, |
||||
| 605 | 26863809 |
CA |
59 | 2 |
Oedema peripheral, Bronchitis, Nasopharyngitis, Fibromyalgia, Malaise, Fatigue, Rheumatoid arthritis, Hypersensitivity, Musculoskeletal stiffness, Duodenal ulcer perforation, Type 2 diabetes mellitus, Adverse event, Therapeutic product effect decreased, Rheumatic fever, Lupus vulgaris, Joint swelling, Hypertension, Alopecia, Decreased appetite, Pemphigus, Therapeutic product effect incomplete, Helicobacter infection, Discomfort, Anti-cyclic citrullinated peptide antibody positive, Retinitis, Hypercholesterolaemia, Abdominal discomfort, Blood cholesterol increased, Hypoaesthesia, Contraindicated product administered, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TELMISARTAN, LANSOPRAZOLE, LANSOPRAZOLE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ASCORBIC ACID, PHENYLEPHRINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, SECUKINUMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DESOXIMETASONE, ERGOCALCIFEROL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, BUPROPION, ACETAMINOPHEN AND CODEINE, LISINOPRIL, CAFFEINE CITRATE, HYDROMORPHONE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BUPROPION HYDROCHLORIDE, SULFASALAZINE, |
||||
| 606 | 26863883 |
US |
||
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 607 | 26864024 |
US |
4 | 2 |
Liver function test abnormal, Infection, Hypersensitivity, |
||||
GUSELKUMAB, |
||||
| 608 | 26864365 |
CA |
19 | 2 |
Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Autoimmune disorder, Blister, C-reactive protein, Condition aggravated, Confusional state, Contusion, Deep vein thrombosis postoperative, Discomfort, Drug intolerance, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Infection, Infusion related reaction, Injury, Joint swelling, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Mobility decreased, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Oedema, Osteoarthritis, Pain, Pemphigus, Pericarditis, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swollen joint count increased, Systemic lupus erythematosus, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Weight increased, Wound, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ACETAMINOPHEN AND CODEINE, LORAZEPAM, CAFFEINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PIROXICAM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LISINOPRIL, MAGNESIUM, MELOXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, ERGOCALCIFEROL, |
||||
| 609 | 26864584 |
CA |
15 | |
Hypersensitivity, Anaphylactic reaction, Inappropriate schedule of product administration, Product dose omission issue, Illness, Intentional dose omission, Suspected off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, RANITIDINE, ALBUTEROL SULFATE, ALBUTEROL, NAPROXEN, NAPROXEN SODIUM, |
||||
| 610 | 26864688 |
|||
Swelling face, Arthralgia, Pain in extremity, Hypersensitivity, |
||||
VARENICLINE, VARENICLINE TARTRATE, |
||||
| 611 | 26864884 |
CN |
||
Bacterial infection, Fungal infection, Viral infection, Cytomegalovirus infection, Epstein-Barr virus infection, Hepatic failure, Haemolysis, Sepsis, Parvovirus B19 infection, Mycoplasma infection, Neutropenia, Thrombocytopenia, Nausea, Decreased appetite, Vomiting, Abdominal pain, Diarrhoea, Constipation, Headache, Dizziness, Hypoaesthesia, Paraesthesia, Tremor, Blood creatinine increased, Renal impairment, Hypersensitivity, Infusion related reaction, Infection, |
||||
RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, CYCLOSPORINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, |
||||
| 612 | 26864909 |
US |
2 | |
Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, OLMESARTAN MEDOXOMIL, |
||||
| 613 | 26865093 |
GB |
81 | 1 |
Urosepsis, Fungal infection, Hypersensitivity, |
||||
DAPAGLIFLOZIN, LANSOPRAZOLE, BISOPROLOL FUMARATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, |
||||
| 614 | 26865352 |
US |
21 | 2 |
Hypersensitivity, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 615 | 26865358 |
US |
79 | 1 |
Hypersensitivity, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 616 | 26865400 |
US |
37 | 2 |
Dermatitis, Skin exfoliation, Rash, Drug ineffective, Hypersensitivity, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 617 | 26865423 |
US |
1 | |
Visual impairment, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 618 | 26865537 |
GB |
2 | |
Aspiration, Bronchitis chemical, Chemical burn of respiratory tract, Chemical burn of respiratory tract, Laryngeal dyskinesia, Stridor, Hypersensitivity, Obstructive airways disorder, |
||||
| 619 | 26865988 |
67 | 2 | |
Hypersensitivity, Throat tightness, Wheezing, Sinus pain, Flushing, Sinusitis, Nasal congestion, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 620 | 26866178 |
GB |
88 | 2 |
Visual impairment, Asthenia, Dizziness, Hypersensitivity, |
||||
FLUCONAZOLE, OXYCODONE HYDROCHLORIDE, OXYCODONE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FLURANDRENOLIDE, BISOPROLOL FUMARATE, ESTRIOL0.2%, ESTRIOL, |
||||
| 621 | 26866325 |
2 | ||
Chest discomfort, Loss of consciousness, Blood pressure systolic increased, Heart rate increased, Chest pain, Presyncope, Dizziness, Chest discomfort, Hypersensitivity, Anxiety, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 622 | 26866530 |
|||
Hypersensitivity, Back pain, |
||||
GLATIRAMER ACETATE, |
||||
| 623 | 26866685 |
US |
2 | |
Hypersensitivity, Asphyxia, Alopecia, Candida infection, |
||||
SIBEPRENLIMAB, BUDESONIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 624 | 26866937 |
MY |
38 | 2 |
Hypersensitivity, Steroid dependence, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, BELIMUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 625 | 26866961 |
US |
2 | |
Burning sensation, Urticaria, Condition aggravated, Hypersensitivity, |
||||
OMALIZUMAB, DUPILUMAB, |
||||
| 626 | 26866971 |
US |
2 | |
Hypersensitivity, |
||||
OMALIZUMAB, OMALIZUMAB, DUPILUMAB, |
||||
| 627 | 26866972 |
EU |
57 | 1 |
Urticaria, Cross sensitivity reaction, Hypersensitivity, |
||||
RIVAROXABAN, APIXABAN, DABIGATRAN ETEXILATE, |
||||
| 628 | 26867071 |
68 | 2 | |
Cardiac failure congestive, Product dispensing error, Hypersensitivity, Nasal congestion, Schizophrenia, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, ROSUVASTATIN, |
||||
| 629 | 26867174 |
US |
78 | |
Product use complaint, Fatigue, Cough, Diarrhoea, Hypersensitivity, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, AMBRISENTAN, FUROSEMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ERGOCALCIFEROL, FUROSEMIDE, TADALAFIL, SOTATERCEPT-CSRK, LATANOPROST, OXYGEN, 0XYGEN, CALCIUM CARBONATE, ANTACID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 630 | 26867196 |
US |
80 | |
Back pain, Pruritus, Pain of skin, Drug intolerance, Dyspnoea, Headache, Oropharyngeal pain, Chest discomfort, Hypersensitivity, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, SELEXIPAG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, FAMOTIDINE, FOLIC ACID, ERGOCALCIFEROL, EMPAGLIFLOZIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MACITENTAN, ALLOPURINOL, ALBUTEROL SULFATE, TADALAFIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SPIRONOLACTONE, OXYGEN, 0XYGEN, TORSEMIDE, |
||||
| 631 | 26867556 |
2 | ||
Cystitis interstitial, Urinary tract infection, Inflammation, Swelling, Poor quality sleep, Hypersensitivity, |
||||
REPOSITORY CORTICOTROPIN, TOCILIZUMAB, ABATACEPT, |
||||
| 632 | 26867720 |
US |
56 | 2 |
Hypersensitivity, |
||||
DENOSUMAB, ACOLTREMON, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, FLUTICASONE PROPIONATE, CHOLESTYRAMINE, LEVOCETIRIZINE DIHYDROCHLORIDE, CLONAZEPAM, SECUKINUMAB, |
||||
| 633 | 26867726 |
US |
61 | 1 |
Nasal polyps, Condition aggravated, Hypersensitivity, Product dose omission issue, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 634 | 26867928 |
CR |
57 | 2 |
Spinal column injury, Spinal cord compression, Lymphadenopathy, Hepatomegaly, Pelvic fracture, Metastases to liver, Renal cyst, Metastases to spine, Metastases to bone, Eye allergy, Musculoskeletal discomfort, Central nervous system lesion, Pain, White blood cell count decreased, Spinal disorder, Mean cell haemoglobin concentration increased, Basophil count increased, Hypersensitivity, Skin irritation, Lymphocyte count decreased, Brain fog, Vitiligo, Erythema, Skin injury, Rash, Back pain, Alopecia, Drug ineffective, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, ZOLEDRONIC ACID, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, |
||||
| 635 | 26857370 |
US |
60 | 1 |
Nasal congestion, Pruritus, Arthralgia, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 636 | 26857506 |
US |
||
Hypersensitivity, Injection related reaction, Intentional product use issue, |
||||
DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MONTELUKAST, METHYLPREDNISOLONE, FAMOTIDINE, |
||||
| 637 | 26857581 |
US |
55 | 2 |
Mood disorder due to a general medical condition, Sleep disorder due to a general medical condition, Pruritus, Hypersensitivity, Swelling of eyelid, Swelling, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 638 | 26857605 |
EU |
58 | |
Seizure, Speech disorder, Hospitalisation, Iridocyclitis, Mycobacterium tuberculosis complex test positive, Tuberculosis, Pyrexia, Back pain, Arthralgia, General physical health deterioration, C-reactive protein increased, C-reactive protein increased, Granuloma, Splenomegaly, Pyrexia, Hypersensitivity, Cough, Drug ineffective, Suspected off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 639 | 26857991 |
CN |
68 | 2 |
Cyanosis, Dyspnoea, Chest discomfort, Blood pressure increased, Respiratory rate increased, Heart rate increased, Flushing, Hyperhidrosis, Hypersensitivity, |
||||
HYDROCORTISONE, SODIUM HYALURONATE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, |
||||
| 640 | 26858345 |
US |
48 | 2 |
Eye inflammation, Nasal inflammation, Ear inflammation, Nasal dryness, Rhinalgia, Ocular hyperaemia, Toothache, Hypersensitivity, Nasal polyps, |
||||
DUPILUMAB, |
||||
| 641 | 26858349 |
US |
74 | 1 |
Rhinorrhoea, Nasal congestion, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 642 | 26858387 |
US |
67 | 2 |
Hypersensitivity, Erythema, Pruritus, |
||||
LENALIDOMIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, CLOPIDOGREL, LACTULOSE, ALPRAZOLAM, OXYCODONE HYDROCHLORIDE, OXYCODONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 643 | 26858427 |
US |
||
Hypersensitivity, |
||||
OCRELIZUMAB, |
||||
| 644 | 26858543 |
US |
2 | |
Hypotension, Hypertension, Increased viscosity of bronchial secretion, Productive cough, Blood pressure fluctuation, Hypersensitivity, Pruritus, Scratch, |
||||
BRENSOCATIB, VALSARTAN, VALSARTAN ORAL, CARVEDILOL, |
||||
| 645 | 26858911 |
EU |
79 | 1 |
Rash erythematous, Hypersensitivity, Dyspnoea, Pulmonary oedema, Cardiomyopathy, Cardiac failure congestive, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, METHYLPREDNISOLONE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, FUROSEMIDE, |
||||
| 646 | 26859074 |
US |
47 | 2 |
Hypersensitivity, Dermatitis atopic, Asthma, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 647 | 26859424 |
US |
35 | 2 |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 648 | 26859658 |
EU |
26 | 2 |
Hypersensitivity, Alanine aminotransferase increased, Insulin C-peptide increased, Gamma-glutamyltransferase increased, Blood glucose increased, Blood lactate dehydrogenase increased, White blood cell count increased, Neutrophil percentage increased, Red cell distribution width increased, Granulocyte count increased, Blood calcium increased, Blood creatinine decreased, Eosinophil count decreased, Blood pressure systolic increased, Blood pressure diastolic increased, Lymphocyte percentage decreased, |
||||
RISDIPLAM, METHYLPREDNISOLONE, |
||||
| 649 | 26859678 |
US |
1 | |
Hypersensitivity, Oral pain, Pain, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL, ASCORBIC ACID, BISOPROLOL FUMARATE, BUDESONIDE, DORZOLAMIDE, FLUTICASONE PROPIONATE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MONTELUKAST, |
||||
| 650 | 26860312 |
CA |
51 | |
Bell^s palsy, Lip swelling, Pharyngeal swelling, Pruritus, Hypersensitivity, |
||||
RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, PROGESTERONE, SULFASALAZINE, |
||||
| 651 | 26860404 |
US |
||
Hypersensitivity, |
||||
ISOTRETINOIN, ISOTRETINOIN, |
||||
| 652 | 26860450 |
US |
38 | 2 |
Pain, Hypersensitivity, Bedridden, |
||||
TRALOKINUMAB-LDRM, |
||||
| 653 | 26860841 |
CA |
58 | 2 |
General physical health deterioration, Dehydration, Nausea, Rash, Oral mucosal blistering, Dysgeusia, Hypersensitivity, |
||||
OSIMERTINIB, |
||||
| 654 | 26860959 |
CA |
44 | 2 |
Maternal exposure timing unspecified, Autoimmune disorder, Contraindicated product administered, Drug intolerance, Gastrointestinal disorder, Glossodynia, Helicobacter infection, Hypersensitivity, Ill-defined disorder, Infusion related reaction, Irritable bowel syndrome, Lower respiratory tract infection, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rheumatoid arthritis, Sinusitis, Stomatitis, Synovitis, Systemic lupus erythematosus, Treatment failure, Weight increased, Wound, Product use issue, Underdose, Prescribed overdose, Suspected off label use, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TOFACITINIB, SULFASALAZINE, SULFASALAZINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, AZATHIOPRINE, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FOLIC ACID, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, ABATACEPT, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, GOLIMUMAB, USTEKINUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, ERGOCALCIFEROL, DICLOFENAC SODIUM, PREDNISONE, CAFFEINE CITRATE, CALCIUM GLUCONATE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, NAPROXEN, NAPROXEN SODIUM, PANTOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, TOFACITINIB CITRATE, |
||||
| 655 | 26861074 |
US |
||
Hypersensitivity, Onycholysis, Skin exfoliation, |
||||
TERBINAFINE HYDROCHLORIDE, |
||||
| 656 | 26861112 |
US |
67 | |
Hypersensitivity, Illness, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 657 | 26861173 |
57 | ||
Hypersensitivity, Generalised oedema, Arthralgia, Drug ineffective, Diarrhoea, Swelling face, Headache, Weight decreased, |
||||
DONIDALORSEN, |
||||
| 658 | 26861713 |
US |
72 | 2 |
Leukopenia, Bronchitis, Follicular lymphoma recurrent, Haemoperitoneum, Hypersensitivity, Tooth infection, Pleural effusion, Hepatic cyst, Atelectasis, |
||||
LENALIDOMIDE, LENALIDOMIDE, OBINUTUZUMAB, |
||||
| 659 | 26861929 |
EU |
||
Throat irritation, Ear discomfort, Hypersensitivity, Dyspnoea, Pain, |
||||
UBLITUXIMAB, |
||||
| 660 | 26862154 |
US |
65 | 1 |
Hypersensitivity, |
||||
IOPAMIDOL, METHYLPREDNISOLONE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 661 | 26862227 |
64 | 1 | |
Hypersensitivity, Eye irritation, Ocular hyperaemia, Vision blurred, Eye swelling, Eye pain, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 662 | 26862375 |
CA |
52 | 2 |
Hypersensitivity, Anxiety, Feeling abnormal, Conversion disorder, |
||||
LISDEXAMFETAMINE, |
||||
| 663 | 26862412 |
EU |
1 | |
Hypersensitivity, Asphyxia, Device delivery system issue, |
||||
| 664 | 26862505 |
US |
63 | |
Illness, Cough, Hypersensitivity, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 665 | 26865741 |
72 | ||
Dizziness, Balance disorder, Fatigue, Confusional state, Stress, Pain, Hypersensitivity, |
||||
EVOLOCUMAB, |
||||
| 666 | 26852682 |
GB |
73 | |
Condition aggravated, Hypersensitivity, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 667 | 26852794 |
US |
||
Hypersensitivity, Swelling face, Urticaria, Peripheral swelling, Nausea, Vomiting, Headache, |
||||
| 668 | 26852795 |
US |
70 | |
Hypersensitivity, Rash, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, ATORVASTATIN CALCIUM, |
||||
| 669 | 26852805 |
CA |
41 | 1 |
Drug-induced liver injury, Enthesopathy, Erythema, Fatigue, Fear of injection, General physical health deterioration, Granuloma skin, Gastrointestinal disorder, Granuloma, Hypercalcaemia, Infusion related reaction, Drug intolerance, Drug tolerance decreased, Drug tolerance, Infection, Headache, Hypertension, Hepatic enzyme increased, Hypersensitivity, Inflammation, Drug ineffective, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, BISOPROLOL FUMARATE, SECUKINUMAB, SECUKINUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, ALENDRONATE SODIUM, ABATACEPT, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, GOLIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, GOLD, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, CYCLOSPORINE, CYCLOSPORINE, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PIROXICAM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, FOLIC ACID, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FOLIC ACID, FOLIC ACID, DIMENHYDRINATE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, ERGOCALCIFEROL, ERGOCALCIFEROL, TOFACITINIB, COLCHICINE, COLCHICINE, COLCHICINE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOXIMETASONE, DESOXIMETASONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, AZATHIOPRINE, |
||||
| 670 | 26852855 |
US |
61 | 2 |
Respiratory disorder, Hypersensitivity, Injection site pain, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 671 | 26853384 |
US |
1 | |
Hypersensitivity, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FERROUS SULFATE, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MONTELUKAST SODIUM, MONTELUKAST, TIRZEPATIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, SILODOSIN, |
||||
| 672 | 26854169 |
CN |
1 | 2 |
Hypersensitivity, Pallor, Cyanosis, Blood pressure decreased, Oxygen saturation decreased, Tachypnoea, Sinus rhythm, Rash maculo-papular, Respiratory distress, |
||||
ALGLUCOSIDASE ALFA, ALGLUCOSIDASE ALFA, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, LORATADINE, LORATADINE ORAL, |
||||
| 673 | 26854364 |
US |
70 | 1 |
Influenza like illness, Chills, Eczema, Skin discolouration, Hypersensitivity, |
||||
MELOXICAM, RITUXIMAB, |
||||
| 674 | 26854387 |
US |
1 | |
Hospitalisation, Surgery, Blood urine present, Vomiting, Hypersensitivity, Nausea, Constipation, |
||||
AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BUMETANIDE, LORATADINE, LORATADINE ORAL, CLOPIDOGREL, CLOPIDOGREL BISULFATE, FLUTICASONE PROPIONATE, GUAIFENESIN, ISOSORBIDE MONONITRATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MAGNESIUM HYDROXIDE, NITROGLYCERIN, POLYETHYLENE GLYCOL, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, OXYBUTYNIN, PANTOPRAZOLE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 675 | 26854509 |
CA |
64 | 2 |
Viral infection, Forced expiratory volume decreased, Middle insomnia, Weight increased, Asthma, Illness, Inappropriate schedule of product administration, Pulmonary function test decreased, Obstructive airways disorder, Reaction to excipient, Nasopharyngitis, Hypertonic bladder, Upper respiratory tract infection, Anaphylactic reaction, Product dose omission issue, Hypersensitivity, Mast cell activation syndrome, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ALBUTEROL SULFATE, |
||||
| 676 | 26855332 |
EU |
79 | 2 |
Hypersensitivity, Stress cardiomyopathy, Kounis syndrome, Cardiac failure congestive, Cardiomyopathy, Haemodynamic instability, |
||||
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, METHYLPREDNISOLONE, FUROSEMIDE, |
||||
| 677 | 26855467 |
US |
60 | |
Headache, Migraine, Hypersensitivity, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 678 | 26855565 |
EU |
29 | 2 |
Hypersensitivity, Acute respiratory distress syndrome, Tachycardia, Hypertension, Contraindicated product administered, |
||||
KETOPROFEN, KETOPROFEN, KETOPROFEN, KETOPROFEN, |
||||
| 679 | 26855743 |
US |
71 | 2 |
Macular degeneration, Empty sella syndrome, Hypothalamo-pituitary disorder, Intracranial pressure increased, Ear pain, Brain fog, CSF volume increased, Intraocular pressure test abnormal, Paranasal sinus discomfort, Lip swelling, Swelling face, Stomatitis, Dry eye, Laboratory test abnormal, Body temperature abnormal, Toxicity to various agents, Blood pressure increased, Drug intolerance, Muscle strain, Wheezing, Eructation, Somnolence, Feeling abnormal, Asthenia, Mood altered, Nervousness, Visual impairment, Spinal stenosis, Blood glucose increased, Headache, Dry mouth, Hypersensitivity, Depression, Pruritus, Middle insomnia, Pain, |
||||
TELMISARTAN, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, ORAL SEMAGLUTIDE, |
||||
| 680 | 26855842 |
US |
2 | |
Hypersensitivity, Off label use, |
||||
ALBUTEROL SULFATE, ATENOLOL, MONTELUKAST SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, |
||||
| 681 | 26856000 |
US |
69 | 1 |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 682 | 26856133 |
US |
81 | 2 |
Hypersensitivity, Rash, Swelling face, Periorbital swelling, Pruritus, |
||||
METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, NIFEDIPINE, |
||||
| 683 | 26856355 |
51 | ||
Injection site erythema, Injection site pain, Injection site pruritus, Injection site urticaria, Hypersensitivity, |
||||
OLEZARSEN SODIUM, ALPRAZOLAM, DULOXETINE HYDROCHLORIDE, DULOXETINE, EZETIMIBE, FENOFIBRATE, FLUCONAZOLE, IRBESARTAN, PANTOPRAZOLE, EVOLOCUMAB, PROPRANOLOL HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, ICOSAPENT ETHYL, |
||||
| 684 | 26856370 |
US |
40 | 2 |
Oropharyngeal pain, Hypersensitivity, Neck pain, Flushing, Abdominal discomfort, Pain of skin, Malaise, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, BACLOFEN, FEXOFENADINE, CETIRIZINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DALFAMPRIDINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, LORATADINE, LORATADINE TABLET, CIMETIDINE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ERGOCALCIFEROL, |
||||
| 685 | 26856381 |
BR |
47 | 2 |
Pathogen resistance, Omphalitis, Dyspepsia, Hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 686 | 26856587 |
BR |
2 | |
Hypersensitivity, Pruritus, Erythema, Off label use, Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 687 | 26856661 |
US |
55 | 2 |
Increased viscosity of upper respiratory secretion, Nasal congestion, Rhinorrhoea, Hypersensitivity, |
||||
BIMEKIZUMAB, |
||||
| 688 | 26857259 |
US |
67 | 2 |
Rash, Eye swelling, Vomiting, Hypersensitivity, |
||||
| 689 | 26862326 |
40 | ||
Eye irritation, Skin burning sensation, Product contamination microbial, Skin discolouration, Rash, Hypersensitivity, |
||||
| 690 | 26846912 |
US |
27 | 2 |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 691 | 26846977 |
GB |
48 | 2 |
Lip swelling, Swelling face, Hypersensitivity, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 692 | 26847250 |
EG |
63 | 2 |
Onychomadesis, Face oedema, Nail discolouration, Skin hyperpigmentation, Lacrimation increased, Flushing, Hypersensitivity, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 693 | 26847420 |
US |
2 | |
Hypersensitivity, Application site injury, |
||||
LIDOCAINE, |
||||
| 694 | 26847792 |
US |
43 | 2 |
Hypersensitivity, Pruritus, |
||||
ORAL SEMAGLUTIDE, TIRZEPATIDE, |
||||
| 695 | 26847794 |
US |
80 | 2 |
Polymyalgia rheumatica, Cataract, Product communication issue, Cyst removal, Stress, Hypersensitivity, |
||||
EVOLOCUMAB, PREDNISONE, |
||||
| 696 | 26847886 |
US |
||
Hypersensitivity, |
||||
| 697 | 26847938 |
CA |
40 | 2 |
Abdominal distension, Confusional state, Dyspepsia, Gastrooesophageal reflux disease, Liver function test increased, Drug hypersensitivity, Glossodynia, Osteoarthritis, Hand deformity, Hypersensitivity, Product label confusion, Onychomadesis, Back injury, Fall, Swelling, Vomiting, Mobility decreased, Hypertension, Dyspnoea, Folliculitis, Nausea, |
||||
DICLOFENAC SODIUM, SARILUMAB, SARILUMAB, LAMOTRIGINE, ADALIMUMAB, ADALIMUMAB, DICLOFENAC SODIUM, SECUKINUMAB, METHYLPREDNISOLONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE, CELECOXIB, CELECOXIB, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, INFLIXIMAB, ETANERCEPT, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CANDESARTAN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MAGNESIUM HYDROXIDE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, LEFLUNOMIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 698 | 26848270 |
EU |
75 | 2 |
Hypersensitivity, |
||||
ACALABRUTINIB, |
||||
| 699 | 26848449 |
CA |
63 | 2 |
Autologous haematopoietic stem cell transplant, Back pain, Diarrhoea, Hepatic enzyme increased, Hypersensitivity, Pyrexia, Intentional product use issue, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LORAZEPAM, BORTEZOMIB, DIMENHYDRINATE, LENALIDOMIDE, MONTELUKAST, SERTRALINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 700 | 26848745 |
EG |
63 | 2 |
Onychomadesis, Skin hyperpigmentation, Hypersensitivity, Flushing, Face oedema, Nail discolouration, Lacrimation increased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30